Population pharmacokinetics and exposure–response of trastuzumab emtansine in advanced breast cancer previously treated with ≥2 HER2‐targeted regimens
Shang‐Chiung Chen; Angelica Quartino; Daniel Polhamus; Matthew Riggs; Jonathan French; Xin Wang; Shweta Vadhavkar; Melanie Smitt; Silke Hoersch; Alexander Strasak; Jin Yan Jin; Sandhya Girish; Chunze Li
Author Information: Genentech, Inc.
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.